Xenon Pharmaceuticals Inc.
XENE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001582313
In the last 90 days, Xenon Pharmaceuticals Inc. insiders filed 2 open-market purchases and 2 sales; 315 institutions reported holding it in 13F filings for Q2 2026, worth $6.10B in total; Duquesne Family Office is the only superinvestor holding it.
Q3 2022 vs. Q2 2022
How the institutions holding Xenon Pharmaceuticals Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 151 | 154 | +3 |
| Shares | 57.0M | 57.9M | +880.8K (+1.5%) |
| Value | $1.73B | $2.09B | +$355.6M (+20.5%) |
New holders (26)
Institutions that held Xenon Pharmaceuticals Inc. at the end of Q3 2022 but not at the end of Q2 2022.
Sold out (23)
Institutions that held Xenon Pharmaceuticals Inc. at the end of Q2 2022 and filed for Q3 2022 without it.